CD36 and metabolic dysfunction-associated steatotic liver disease: In preclinical models of NAFLD, NAC blocked hepatic lipid accumulation, which indicates that NAC can regulate fatty acid scavenger molecule CD36 and transcriptional factors, such as Srebp-1c [45].